BrainStorm gets FDA fast-track status for ALS stem cell therapy – Reuters
|
BrainStorm gets FDA fast-track status for ALS stem cell therapy
Reuters TEL AVIV (Reuters) – Israel’s BrainStorm Cell Therapeutics said the U.S. Food and Drug Administration has designated its adult stem cell treatment as a “fast-track” product for the treatment of amyotrophic lateral sclerosis (ALS). BrainStorm’s … |
|
Cancer toddler family’s campaign to raise awareness
ITV News The day is designed to promote awareness around the need for more potential stem cell donors to join the UK and worldwide registries. It will give particular encouragement to those with mixed race to register, as this is a stem bank that is under … |